JW Shinyak Corporation (067290) - Total Liabilities
Based on the latest financial reports, JW Shinyak Corporation (067290) has total liabilities worth ₩26.02 Billion KRW (≈ $17.63 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 067290 cash generation efficiency to assess how effectively this company generates cash.
JW Shinyak Corporation - Total Liabilities Trend (2007–2024)
This chart illustrates how JW Shinyak Corporation's total liabilities have evolved over time, based on quarterly financial data. Check 067290 financial resilience to evaluate the company's liquid asset resilience ratio.
JW Shinyak Corporation Competitors by Total Liabilities
The table below lists competitors of JW Shinyak Corporation ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Duroc AB (publ)
ST:DURC-B
|
Sweden | Skr970.50 Million |
|
Nebag ag
SW:NBEN
|
Switzerland | CHF42.11K |
|
iBio, Inc. Common Stock
NASDAQ:IBIO
|
USA | $7.83 Million |
|
CSL Finance Limited
NSE:CSLFINANCE
|
India | Rs8.10 Billion |
|
International Conveyors Limited
NSE:INTLCONV
|
India | Rs1.69 Billion |
|
Cheetah Mobile Inc
NYSE:CMCM
|
USA | $2.80 Billion |
|
Frontier Nuclear and Minerals Inc.
NASDAQ:FNUC
|
USA | $11.14 Million |
|
Awilco LNG ASA
OL:ALNG
|
Norway | Nkr192.06 Million |
Liability Composition Analysis (2007–2024)
This chart breaks down JW Shinyak Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see JW Shinyak Corporation (067290) market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.27 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.67 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.40 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how JW Shinyak Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for JW Shinyak Corporation (2007–2024)
The table below shows the annual total liabilities of JW Shinyak Corporation from 2007 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩36.14 Billion ≈ $24.49 Million |
-26.52% |
| 2023-12-31 | ₩49.17 Billion ≈ $33.32 Million |
+29.00% |
| 2022-12-31 | ₩38.12 Billion ≈ $25.83 Million |
+4.27% |
| 2021-12-31 | ₩36.56 Billion ≈ $24.78 Million |
-8.07% |
| 2020-12-31 | ₩39.77 Billion ≈ $26.95 Million |
-43.76% |
| 2019-12-31 | ₩70.71 Billion ≈ $47.92 Million |
-6.61% |
| 2018-12-31 | ₩75.72 Billion ≈ $51.31 Million |
-12.49% |
| 2017-12-31 | ₩86.53 Billion ≈ $58.64 Million |
-17.60% |
| 2016-12-31 | ₩105.01 Billion ≈ $71.16 Million |
+20.08% |
| 2015-12-31 | ₩87.45 Billion ≈ $59.26 Million |
+3.45% |
| 2014-12-31 | ₩84.53 Billion ≈ $57.29 Million |
+3.88% |
| 2013-12-31 | ₩81.38 Billion ≈ $55.15 Million |
+23.04% |
| 2012-12-31 | ₩66.14 Billion ≈ $44.82 Million |
+32.31% |
| 2011-12-31 | ₩49.99 Billion ≈ $33.88 Million |
+135.31% |
| 2008-12-31 | ₩21.24 Billion ≈ $14.40 Million |
-0.58% |
| 2007-12-31 | ₩21.37 Billion ≈ $14.48 Million |
-- |
About JW Shinyak Corporation
JW Shinyak Corporation, a pharmaceutical company, engages in the production and sale of medicines and medical supplies in South Korea. The company offers pharmaceutical products in the areas of dermatology, urology, pediatrics, otolaryngology, etc.; and cardiovascular, gastrointestinal, urinary, NSAIDs, antibiotics, anti-fungal, anti-viral, respiratory, antihistamines, steroid hormone, anti-obesi… Read more